Spots Global Cancer Trial Database for Saliva mRNA Expression Profiling for Early Stage Non-Small Cell Lung Cancer Screening
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Saliva mRNA Expression Profiling for Early Stage Non-Small Cell Lung Cancer Screening
Official Title: Saliva mRNA Expression Profiling for Early Stage Non-Small Cell Lung Cancer Screening
Study ID: NCT00607425
Conditions
Interventions
Study Description
Brief Summary: This is a pilot study to test the feasibility of using gene expression from saliva to identify patients with early-stage non-small cell lung cancer (NSCLC). The primary objective of this study is to compare gene expression profiles from saliva from healthy controls and patients with early-stage non-small cell lung cancer. To be eligible, patients with non-small cell lung cancer, must not yet have received treatment for their cancer (surgical removal, chemotherapy, or radiation therapy). Health control participants may participate if they meet eligibility criteria listed below. Eligible enrollees will be asked to submit a one time saliva sample and complete a study questionaire.
Detailed Description:
Eligibility
Minimum Age: 40 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Contact Details
Name: Glen J Weiss, MD
Affiliation: TGen Clinical Research Services at Scottsdale Healthcare
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
